Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06952439 · ClinicalTrials.gov registry record
Clinical Performance Evaluation of the Artificial Intelligence (AI)/ Machine Learning (ML) Technologies Utilized by the Origin Medical EXAM ASSISTANT
A clinical trial of To Validate the Clinical Performance of AI/ML Technologies in First-trimester Pregnant Participants and First Trimester Pregnancy, sponsored by Origin Medical Systems.
- Completed
- Registry status
- 551
- Enrollment target
- 15
- Study locations
NCT06952439 is a study of To Validate the Clinical Performance of AI/ML Technologies in First-trimester Pregnant Participants and First Trimester Pregnancy that has completed, run by Origin Medical Systems. The registered enrollment target is 551 participants. The trial reports 15 study locations across 6 states.
The verdict
NCT06952439, a study of To Validate the Clinical Performance of AI/ML Technologies in First-trimester Pregnant Participants and First Trimester Pregnancy, has completed, sponsored by Origin Medical Systems.
- COMPLETED
- Registry status
- 551 participants
- Enrollment target
- 15
- Study locations
Study Summary
A multicenter study will be conducted to assess the role of the AI/ML technologies of Origin Medical EXAM ASSISTANT (OMEA) in interpreting first-trimester fetal ultrasound examinations (11 weeks 0 days - 13 weeks 6 days). The performance of the AI-based system will be compared against the ground truth provided by an independent reading panel of maternal-fetal medicine physicians.
Conditions Studied
Interventions
- DEVICE Images and cines captured through the capture card (ICC)
Study Locations (15)
California
- Harbinder S Brar MD Inc - Apple Valley
- Harbinder S Brar MD Inc - Indio
- Harbinder S Brar MD Inc - Murrieta
- Harbinder S Brar MD Inc - Redlands
- Harbinder S Brar MD Inc - Riverside
- Harbinder S Brar MD Inc - San Bernardino
Oklahoma
- The Nest 4D Ultrasound LLC, DBA InFocus Ultrasound DBA Little Peanut 4D Ultrasound - Norman
- The Nest 4D Ultrasound LLC, DBA InFocus Ultrasound DBA Little Peanut 4D Ultrasound - Oklahoma City
- Tiny Blessings Ultrasound 4D Studio - Owasso
- Tiny Blessings Ultrasound 4D Studio - Skiatook
Texas
- Total Womens Care PLLC - Houston
- Reveal Ultrasound, LLC-S - Webster
Louisiana
- Sweet Pea 3D/4D Ultrasound Nola - New Orleans
New York
- Mobile Mama Ultrasound, LLC - Troy
North Carolina
- Mid-Carolina OB/GYN - Raleigh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 551 participants |
| Start Date | 2025-03-19 |
| Est. Completion | 2025-05-19 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06952439
The ClinicalTrials.gov registry entry for NCT06952439 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 551 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Origin Medical Systems, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with To Validate the Clinical Performance of AI/ML Technologies in First-trimester Pregnant Participants appearing as the primary indexed condition, and to 1 intervention - of which Images and cines captured through the capture card (ICC) is the first listed.
NCT06952439 reports 15 study locations spanning 6 distinct geographic areas - top geographies include California, Oklahoma, Texas.
Frequently Asked Questions
What is clinical trial NCT06952439 about?
NCT06952439 is a clinical study titled "Clinical Performance Evaluation of the Artificial Intelligence (AI)/ Machine Learning (ML) Technologies Utilized by the Origin Medical EXAM ASSISTANT". A multicenter study will be conducted to assess the role of the AI/ML technologies of Origin Medical EXAM ASSISTANT (OMEA) in interpreting first-trimester fetal ultrasound examinations (11 weeks 0 days - 13 weeks 6 days). The performance of the AI-based system will be compared against the ground tru...
What is the current status of trial NCT06952439?
This trial is currently completed. The enrollment target is 551 participants. The study started on 2025-03-19. Estimated completion is 2025-05-19.
What conditions does trial NCT06952439 study?
This clinical trial studies the following conditions: To Validate the Clinical Performance of AI/ML Technologies in First-trimester Pregnant Participants, First Trimester Pregnancy.
What interventions are being tested in trial NCT06952439?
The interventions under investigation include: Images and cines captured through the capture card (ICC) (DEVICE).
Who is sponsoring clinical trial NCT06952439?
This trial is sponsored by Origin Medical Systems, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06952439 being conducted?
This trial has 15 study locations across California, Louisiana, New York, North Carolina, Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Explore more on PlainTrial
To Validate the Clinical Performance of AI/ML Technologies in First-trimester Pregnant Participants
All registered trials for this condition
First Trimester Pregnancy
All registered trials for this condition
California
All trials with a study site in California
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.